![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » WHO Says ‘No’ to Convalescent Plasma for Nonsevere COVID-19
WHO Says ‘No’ to Convalescent Plasma for Nonsevere COVID-19
The World Health Organization (WHO) has recommended against the use of convalescent plasma for treating patients with nonsevere COVID-19 and said it should only be given within the context of clinical trials for severe and critical coronavirus patients.
A review of 16 different trials that included 16,236 COVID-19 patients with nonsevere, severe and critical COVID-19 infection found that the plasma did not improve survival or reduce the need for supplemental oxygen for nonsevere patients, a WHO panel found.
But the WHO said the available evidence is less certain for severe and critically ill COVID-19 patients and suggested trials continue for this subgroup.
Upcoming Events
-
18Jul
-
21Oct